logo
  

Engine Capital Favors Merger Of PFSweb, Speed Commerce

Engine Capital LP, a shareholder of each of PFSweb Inc (PFSW) and Speed Commerce Inc (SPDC), on Monday said that a combination of the two companies would create strong growth opportunities.

Speed Commerce provides e-commerce and fulfillment services to retailers and manufacturers, while PFSweb provides business process outsourcing and ecommerce solutions.

Engine Capital, which owns a stake of about 4% of PFSweb and 3% of Speed Commerce, in a communique to both companies, said, "While we think that both companies have significant and exciting standalone prospects, we think that a merger of both companies offers an opportunity to create significant additional value that would not detract in any way from the existing opportunities of both companies."

"A strategic combination would create a juggernaut in the space that would be the unequivocal number-two player behind eBay Enterprise."

Engine Capital further said, "Instead of having the number- two and number-three players (PFSW and SPDC) compete against each other for business, this combination would create a number-two player with significant scale, additional revenue opportunities, significant cost savings opportunities, and potential multiple rerating."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT